Aziz Ul-Haq discusses how LDC is supporting its healthcare portfolio companies to achieve their growth strategies in a fast-moving market.

Younes Fegheh-Hassanpour, R&D tax manager at financial advisor RCK Partners explains how the UK can spark global competitiveness in the life sciences industry

Jay Shah ponders whether CDMO deals will revive next year to define pharma M&A.